Refresh

Medicamen Biotech Ltd. - Research Center

531146 MEDICAMEQ Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

137.88 115.45 110.15 117.34 122.60
Expenses

Material consumed

71.82 52.62 67.42 74.15 83.90

Manufacturing expenses

13.56 12.94 9.20 10.36 7.28

Personnel expenses

18.57 14.50 8.79 9.29 8.09

Selling expenses

0.02 0.36 0.01 0.01 0.01

Adminstrative expenses

9.77 11.47 5.14 5.77 6.31

Expenses capitalised

- - - - -

Cost of sales

113.74 91.89 90.57 99.58 105.59

Operating profit

24.15 23.56 19.58 17.76 17.02

Other recurring income

2.46 1.72 0.75 1.91 3.66

Adjusted PBDIT

26.61 25.28 20.33 19.67 20.67

Financial expenses

2.92 1.40 1.06 0.57 0.94

Depreciation

6.35 5.77 2.52 2.50 2.21

Other write offs

- - - - -

Adjusted PBT

17.33 18.10 16.75 16.60 17.52

Tax charges

2.33 3.20 4.26 4.34 5.50

Adjusted PAT

15.00 14.91 12.49 12.26 12.03

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

15.00 14.91 12.49 12.26 12.03

Earnigs before appropriation

83.12 69.34 55.04 44.03 31.77

Equity dividend

1.27 1.22 0.61 1.47 -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

81.85 68.12 54.43 42.56 31.77
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com